FDA Cites Sterile Drugmaker Over Sanitation, Complaints and Product Discrepancies

Drug Industry Daily
A A
The FDA flagged Horizon Pharmaceuticals for failure to follow sanitation procedures, insufficient investigations into customer complaints and inadequate reviews of product discrepancies, among other issues.

To View This Article:

Login

Subscribe To Drug Industry Daily